RFK Jr. pulls $500M in funding for vaccine development
9 months ago
- #public health
- #vaccines
- #mRNA
- RFK Jr. cancels $500 million in funding for mRNA vaccine development targeting respiratory viruses like COVID-19 and flu.
- Decision includes halting 22 projects led by major pharmaceutical companies such as Pfizer and Moderna.
- Kennedy criticizes mRNA vaccines, advocating for alternative strategies like whole-virus vaccines.
- Infectious disease experts warn the move is dangerous, citing mRNA's role in pandemic response and rapid production benefits.
- Scientists highlight mRNA's broader potential, including cancer immunotherapy research.
- HHS clarifies other mRNA applications remain unaffected, signaling a shift in vaccine development priorities.